🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on the social media company, the platform has taken down violative content and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.

After minutes of joining one group, a seller posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Item Information and Pricing

Within these groups, messages display dark colored packages with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious health risks”.